Program Release: April 26, 2021
Expiration Date: April 26, 2023
Estimated time to complete: 60 Minutes
There are no prerequisites for participation
This program describes the current evidence for treatment of opioid use disorder in the Emergency Department and outlines practices for clinical management of patients with opioid use disorder. Practical instruction for initiation of medications for use disorder is provided. The goal by the end of the lecture is that providers will feel comfortable offering and providing a spectrum of evidence-based care for patients with opioid use disorder in the ED including medications for opioid use disorder naloxone, harm reduction resources, and linkage to follow up substance use treatment services and peer recovery specialists.
ACKNOWLEDGEMENT OF FUNDING
Funding provided by a Centers for Disease Control and Prevention ROI CE1900I Grant
After participating in this activity, the learner should be better able to:
Identify management strategies for patients with opioid use disorder experiencing acute pain or undergoing surgery
Describe the current state of evidence around peri-operative management of patients taking buprenorphine
Access the various resources available to aid in management of patients with opioid use disorder experiencing acute pain or undergoing surgery
METHOD OF PARTICIPATION AND HOW TO RECEIVE CME CREDIT
Review the activity objectives, faculty information, and CME information prior to participating in the activity.
View the presentation
Complete the quiz with a passing score of 75% or higher, as well as the activity evaluation. You will then have immediate access to claiming credit and obtaining your certificate.
In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.
This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.
Faculty Disclosure/Conflict of Interest
The following speakers and planning committee members* have indicated that they have no relevant financial relationships to disclose:
Collette Onyejekwe, PharmD, RPh* Elizabeth Samuels, MD, MPH, MHS Maria Sullivan* Rachel S. Wightman, MD
Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.